|View printer-friendly version|
Ms. Huss is an accomplished chief executive officer who brings more than 22 years of management experience in the medical device industry. Since 2013 she has served as president and chief executive officer of Qool Therapeutics, formerly
"We are extremely pleased to welcome
"I'm thrilled to have the opportunity to join
With the appointment of Ms. Huss,
+1 (646) 445-4800
+1 (408) 789-4426
View original content with multimedia:http://www.prnewswire.com/news-releases/beverly-a-huss-joins-accuray-board-of-directors-300581654.html
© 2007 - 2016 Accuray Incorporated. All Rights Reserved. Accuray, the stylized logo, CyberKnife, TomoTherapy, Synchrony, Xsight, Xchange, TomoHD, Hi-Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.
Important Safety Information: Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death.
Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient's general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.